Lincoln Pharmaceuticals Limited

Web: lincolnpharma.com NSE: LINCOLN BSE: 531633 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

623 0(0%)

Volume

34k as on 23, Jun

Open

805

High

810

Low

795

623

VWAP

614

52 Week High

770

52 Week Low

440

Viand Research Rating

Quality Score

55/100

Growth Score

24/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,248

No. of Shares

P/E

13.19

P/B

2.15

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

16.3

ROCE

Profit Growth

Listing Date

17-Dec-15

Promoter Holding

49.78%

FII Holding

4.6%

DII Holding

0.27%

Price Chart

Price Performance

1 Week6%

1 Month17%

3 Months3%

6 Months4%

1 Year4%

YTD4%

Moving Average

5 Day SMA615

10 Day SMA627

20 Day SMA635

30 Day SMA654

50 Day SMA645

61 Day SMA632

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	633	620	628	635
Resistance 2	628	619	624	629
Resistance 1	623	618	621	624
Pivot Point	617	617	617	618
Support 1	612	616	613	614
Support 2	606	615	611	607
Support 3	601	614	606	603

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 49.78%	(0.01) 49.78%	(0.01) 49.78%	(0.01) 49.78%	(0.01) 49.78%	(0.01) 49.78%	(0.01) 49.78%	(0.01) 49.78%	(0.21) 49.78%	(-0.31) 49.54%	(-0.71) 49.81%	(1.91) 50.53%	(1.71) 48.68%	(0.71) 47.00%	(2.31) 46.34%	(0.01) 44.09%	(2.01) 44.08%	(0.01) 42.05%	(1.81) 42.08%	(0.01) 40.28%
FIIs	(-0.61) 4.60%	(0.51) 5.20%	(0.01) 4.70%	(-0.41) 4.73%	(0.11) 5.13%	(-0.21) 5.00%	(0.01) 5.16%	(1.21) 5.19%	(0.01) 3.95%	(0.71) 3.93%	(0.61) 3.22%	(0.91) 2.59%	(0.51) 1.74%	(-0.21) 1.27%	(0.81) 1.44%	(0.01) 0.63%	(-0.11) 0.64%	(-0.21) 0.77%	(0.21) 0.95%	(0.01) 0.75%
DIIs	(-0.81) 0.27%	(1.11) 1.08%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.04%	(0.01) 0.05%	(0.11) 0.06%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Public	45.36%	43.94%	45.51%	45.49%	45.08%	45.23%	45.07%	45.04%	46.24%	46.49%	46.92%	46.87%	49.57%	51.74%	52.22%	55.29%	55.28%	57.19%	56.97%	58.97%
No. of Shareholders	29,396	28,303	31,026	32,370	31,784	31,867	31,848	31,330	29,967	31,375	29,316	28,670	27,480	29,088	29,846	31,731	31,902	32,447	31,913	30,274

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	177	187	166	163	154	168	147	161	147	142	146	156	136	112	134	141	123	103	120	127	122
Sales Growth % (YoY)	15.1%	11.4%	13.5%	1.3%	4.6%	18%	0.1%	3.4%	8.6%	26.7%	9.5%	10.9%	9.8%	9.6%	11.6%	10.3%	1%	28.9%	4.5%	1.1%	17.7%
Sales Growth % (QoQ)	-5.3%	12.7%	1.8%	5.8%	-8.3%	14.3%	-8.7%	9.5%	3.5%	-2.7%	-6.4%	14.7%	21.4%	-16.4%	-5%	14.6%	19.4%	-14.2%	-5.5%	4.1%	-
Expenses	150	162	143	138	130	141	123	133	125	124	117	125	115	96	107	112	107	85	96	98	97
Operating Profit	27	25	24	25	24	27	24	28	23	18	30	31	21	17	27	29	17	17	23	29	25
OPM %	15	13	14	16	15	16	16	18	15	13	20	20	15	15	20	21	14	17	20	23	21
Other Income	24	-4	15	7	15	-7	9	10	10	7	11	9	8	4	6	6	6	2	3	3	2
Interest	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	1	0	0	0
Depreciation	4	4	4	4	3	3	3	3	3	3	3	3	3	2	2	2	2	2	2	2	2
Profit before tax	48	17	35	29	35	16	29	35	29	22	38	37	25	17	31	32	21	17	24	31	25
Tax %	24	30	18	31	22	29	28	24	20	16	26	25	25	26	29	26	28	34	25	25	29
Net Profit	36	12	29	20	28	12	21	26	24	19	28	28	19	13	22	24	15	11	18	23	18
Net Profit Growth % (QoQ)	200%	-58.6%	45%	-28.6%	133.3%	-42.9%	-19.2%	8.3%	26.3%	-32.1%	-	47.4%	46.2%	-40.9%	-8.3%	60%	36.4%	-38.9%	-21.7%	27.8%	-
Net Profit Growth % (YoY)	28.6%	-	38.1%	-23.1%	16.7%	-36.8%	-25%	-7.1%	26.3%	46.2%	27.3%	16.7%	26.7%	18.2%	22.2%	4.3%	-16.7%	-	-	-	-
TTM Net Profit	97	89	89	81	87	83	90	97	99	94	88	82	78	74	72	68	67	70	59	41	0
EPS in Rs	18.09	5.81	14.28	9.98	13.82	5.78	10.37	13.15	11.82	9.29	14	13.8	9.49	6.27	10.79	11.84	7.49	5.5	8.79	11.52	8.85

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	671	623	581	510	472	424	386	366	361	360	400	266	210	195
Sales Growth %	7.7%	7.4%	13.8%	8.1%	11.3%	9.8%	5.6%	1.5%	0.1%	-10%	50.4%	26.4%	8.1%	3.8%
Expenses	573	522	480	421	376	337	321	299	308	313	359	240	190	179
Operating Profit	98	102	100	90	96	87	66	68	53	47	41	26	20	16
OPM %	15	16	17	18	20	21	17	18	15	13	10	10	10	8
Other Income	33	22	34	22	10	5	11	5	5	2	7	7	2	6
Interest	1	2	1	2	1	2	2	4	5	7	10	8	7	8
Depreciation	14	13	11	9	8	8	7	7	6	6	5	5	4	3
Profit before tax	116	109	122	100	96	84	67	62	46	37	33	20	12	11
Tax %	24	25	24	27	28	26	23	22	25	25	28	24	16	16
Net Profit	88	82	93	73	69	62	51	49	35	28	24	15	10	10
Net Profit Growth %	7.3%	-11.8%	27.4%	5.8%	11.3%	21.6%	4.1%	40%	25%	16.7%	60%	50%	-	-
EPS in Rs	43.88	41.11	46.58	36.4	34.63	31.12	25.72	24.36	17.31	14.06	14.52	9.2	6.53	5.92
Dividend Payout %	4	4	4	4	4	5	6	6	9	9	7	11	9	10

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	106	93	63	39	76	69	75	53	27	25	45	25	5	-16
Cash from Investing Activity	-98	-79	-57	-37	-78	-64	-31	-18	-12	-25	-42	7	1	-16
Cash from Financing Activity	0	-6	-5	-4	-3	-6	-38	-36	-11	0	-3	-32	-11	29
Net Cash Flow	8	8	1	-2	-4	-1	7	-1	3	0	0	-1	-4	-3

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	20	20	20	20	20	20	20	20	20	20	20	20	16	16	16	16
Reserves	738	696	652	619	573	482	413	346	293	249	204	172	124	95	82	73
Borrowings	4	0	0	1	1	2	2	1	5	34	61	64	78	76	68	76
Other Liabilities	128	139	125	139	106	83	99	85	71	63	62	48	56	70	93	72
Total Liabilities	890	855	797	780	700	587	534	452	389	366	347	305	275	258	260	237
Fixed Assets	191	185	182	177	179	151	132	111	123	121	117	103	98	66	65	65
CWIP	5	3	4	7	3	7	16	2	0	2	0	7	3	3	2	2
Investments	209	209	174	164	139	91	97	81	34	18	11	10	0	0	0	0
Other Assets	486	458	437	432	379	339	290	259	232	225	219	186	174	190	192	169
Total Assets	890	855	797	780	700	587	534	452	389	366	347	305	275	258	260	237

Delivery

Delivery Data: LINCOLN

#	Date	570 14% 647	Value (Cr)	Q/T 20	Del 44	Del 5
1	4-Sep	621	2	23	62	1
2	3-Sep	623	1	20	54	1
3	2-Sep	618	3	19	50	2
4	1-Sep	610	1	15	45	1
5	31-Aug	607	2	18	49	1
6	28-Aug	615	1	18	56	1
7	27-Aug	614	1	12	49	0
8	26-Aug	613	2	7	54	1
9	25-Aug	618	3	20	52	1
10	24-Aug	612	1	15	66	1
11	21-Aug	614	1	14	55	1
12	20-Aug	623	1	14	58	1
13	19-Aug	610	1	19	57	1
14	18-Aug	619	2	18	64	1
15	17-Aug	623	2	19	52	1
16	14-Aug	613	8	20	37	3
17	13-Aug	620	66	33	16	11
18	12-Aug	593	2	20	61	1
19	11-Aug	596	3	30	53	2
20	10-Aug	595	1	14	63	1
21	7-Aug	600	1	19	50	1
22	6-Aug	606	2	20	56	1
23	5-Aug	611	3	18	63	2
24	4-Aug	593	3	18	58	1
25	3-Aug	581	1	19	68	1
26	31-Jul	577	1	20	72	1
27	30-Jul	572	1	17	62	1
28	29-Jul	581	0	10	59	0
29	28-Jul	579	1	15	55	0
30	27-Jul	582	1	12	55	0
31	24-Jul	580	1	15	56	0
32	23-Jul	587	1	17	62	1
33	22-Jul	577	2	19	65	1
34	21-Jul	598	1	21	58	1
35	20-Jul	597	1	16	56	1
36	17-Jul	597	1	19	66	1
37	16-Jul	602	2	25	55	1
38	15-Jul	604	2	18	46	1
39	14-Jul	607	2	33	64	1
40	13-Jul	610	1	18	60	1
41	10-Jul	616	2	13	55	1
42	9-Jul	612	1	18	44	1
43	8-Jul	601	1	17	63	1
44	7-Jul	620	1	21	54	1
45	6-Jul	615	2	30	53	1
46	3-Jul	620	1	29	61	1
47	2-Jul	624	1	29	67	1
48	1-Jul	622	2	27	40	1
49	30-Jun	624	1	20	60	1
50	29-Jun	626	2	19	42	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	1,248c	5c	0.40
03-Sep	1,243c	22c	1.81
01-Sep	1,221c	8c	0.63
31-Aug	1,228c	30L	0.02
26-Aug	1,228c	80L	0.07
25-Aug	1,229c	3c	0.25
24-Aug	1,226c	18c	1.46
21-Aug	1,244c	6c	0.49
19-Aug	1,238c	1c	0.08
18-Aug	1,237c	13c	1.04
17-Aug	1,250c	24c	1.94
14-Aug	1,226c	8c	0.64
13-Aug	1,218c	24c	2.05
12-Aug	1,194c	2c	0.20
11-Aug	1,196c	30L	0.03
10-Aug	1,196c	13c	1.04
07-Aug	1,208c	13c	1.03
06-Aug	1,221c	70c	6.12
04-Aug	1,151c	4c	0.32
31-Jul	1,154c	7c	0.61
30-Jul	1,161c	4c	0.35
29-Jul	1,166c	12c	1.02
28-Jul	1,154c	15c	1.32
27-Jul	1,169c	0	0

Stock Checklist

Price is above from 52 week high low average: 55%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	-	0

Lincoln Pharmaceuticals Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements